Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07114744 · ClinicalTrials.gov registry record
Early Cochlear Implant Use
A clinical trial of Cochlear Implant Users, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT07114744: Recruiting study of Cochlear Implant Users, sponsored by NYU Langone Health.
NCT07114744 is a study of Cochlear Implant Users that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07114744, a study of Cochlear Implant Users, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This observational study will examine newly activated cochlear implant users and determine whether their abilities to discern simple sounds change and relate to improved speech perception. Take-home computers and test-equipment will be sent home, and subjects will complete approximately 25 test sessions over the first 3 months of cochlea implant use. Then, subjects will be tested 3 more times in the laboratory until 1 year-post activation. The primary objective is to determine and quantify how sounds change and speech perception improves over the course of early cochlear implant use.
Primary Outcome
Speech perception tests involves presentation of a speech stimulus (may be a word, sentence, nonsense words, or other speech sounds) and subjects will have to indicate what they heard. The total score is the percentage of speech stimulus correctly understood, ranging from 0-100%.
Conditions Studied
Interventions
- OTHER Take home tests
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2027-07-01 |
What NCT07114744 shows while recruiting
NCT07114744 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Cochlear Implant Users appearing as the primary indexed condition, and to 1 intervention - of which Take home tests is the first listed.
NCT07114744 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07114744 about?
NCT07114744 is a clinical study titled "Early Cochlear Implant Use". This observational study will examine newly activated cochlear implant users and determine whether their abilities to discern simple sounds change and relate to improved speech perception. Take-home computers and test-equipment will be sent home, and subjects will complete approximately 25 test sess...
What is the current status of trial NCT07114744?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-06-11. Estimated completion is 2027-07-01.
What conditions does trial NCT07114744 study?
This clinical trial studies the following conditions: Cochlear Implant Users.
What interventions are being tested in trial NCT07114744?
The interventions under investigation include: Take home tests (OTHER).
Who is sponsoring clinical trial NCT07114744?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07114744 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cochlear Implant Users
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI